JGCM
BIIB icon

Joseph Group Capital Management’s Biogen BIIB Stock Holding History

Joseph Group Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.4K Sell
25
-11
-31% -$2.1K ﹤0.01% 382
2026
Q1 		$6.6K Buy
+36
New +$6.63K ﹤0.01% 348

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Joseph Group Capital Management's BIIB Position: Q2 2026 in Review

Joseph Group Capital Management reduced its Biogen (BIIB) stake by 31% in Q2 2026, selling an estimated $2.1K and leaving 25 shares worth $5.4K. The position accounts for ﹤0.01% of the portfolio, ranked #382.

Joseph Group Capital Management first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.6K in Q1 2026. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Joseph Group Capital Management held 25 shares of Biogen worth $5.4K as of Q2 2026.
  • Joseph Group Capital Management sold 11 Biogen shares in Q2 2026, an estimated $2.1K.
  • Biogen made up ﹤0.01% of Joseph Group Capital Management's portfolio in Q2 2026, its #382 holding.
  • Joseph Group Capital Management first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
  • Joseph Group Capital Management's Biogen position peaked at $6.6K in Q1 2026.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Joseph Group Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.